Candioli Pharma, founded in 1882 in Turin, Italy, is one of Europe’s most established pharmaceutical companies, with more than a century of experience in advancing animal health. Built on a legacy of scientific research and innovation, Candioli Pharma has grown into a trusted global brand, delivering high-quality veterinary products that support the well-being of pets worldwide.

Within the veterinary sector, Candioli Pharma is especially recognized for its expertise in developing solutions for chronic health conditions. Its flagship products, Renal N and Renal P, are widely recommended by veterinarians to support kidney function in cats and dogs, offering scientifically formulated nutritional support for managing renal disease and improving pets’ quality of life.

In addition, Candioli Pharma provides effective solutions in other specialized areas. Forbid Powder is a unique aid designed to reduce and manage coprophagia (stool-eating behavior) in pets, while Evexia HF offers advanced support for chronic pain and inflammation, helping pets regain mobility and comfort in their daily lives.

With over 140 years of history, Candioli Pharma continues to combine tradition with innovation, ensuring every product meets the highest standards of safety, efficacy, and quality. Today, veterinarians and pet owners around the world trust Candioli’s range of products as reliable solutions for long-term animal health management.

In Malaysia, these veterinary innovations are distributed by Pawxie Sdn Bhd, making Candioli’s trusted products accessible to veterinary professionals who strive to deliver the best care for their patients.